-
Uncategorized1 week agoSTAT+: Trump administration to strip job protections of top NIH officials, grants staff
President Trump issued an executive order on Wednesday defining thousands of positions within the civil service sector that the administration will reclassify as political appointees. Among...
-
Uncategorized1 week ago
Marked for destruction
Nature Biotechnology, Published online: 04 June 2026; doi:10.1038/s41587-026-03182-5 The significance of the first FDA-approved PROTAC lies not in proving that targeted protein degradation is superior to...
-
Uncategorized1 week agoSTAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Jakob Uszkoreit went from inventing the “T” in ChatGPT to putting the “AI” in Alnylam’s RNAi therapeutics. After over a dozen years at Google, where he’d...
-
Uncategorized1 week ago
Human Hookworm Engineered to Produce, Secrete Anti-Tetrodotoxin Antibody Into Preclinical Host Bloodstream
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for...
-
Uncategorized1 week ago
Small Molecules to Big Partnership: Incyte, Genesis Expand AI Collaboration to $1B+
Drug collaborations don’t always work out as planned. Sometimes they work out better. When Incyte agreed last year to partner with artificial intelligence (AI) platform developer...
-
Uncategorized1 week ago
FDA hits Medline with warning letter over long-running contamination problem
FDA hits Medline with warning letter over long-running contamination problem
-
Uncategorized1 week agoHerantis to advance Alzheimer’s treatment after FDA meeting
Herantis is set to advance the clinical development of its Alzheimer’s therapy following a positive meeting with the US Food and Drug Administration (FDA). The company reports...
-
Uncategorized1 week ago
Bioproduction Pivots from Centralized to Regional Support
The global biopharma industry is placing increasing importance on regional support rather than only centralized expertise to help complex programs advance. A key benefit is access...
-
Uncategorized1 week agoLegend surges on early data for ‘in vivo’ lymphoma cell therapy
Initial findings show that the therapy reduced or eliminated disease signs in all recipients, sparking hopes that the treatment might be competitive with “ex vivo” medicines...
-
Uncategorized1 week agoHouse bill aims to crack down on China biotech deals
A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S. fears that China’s drugmaking...
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
An obesity drug deep-dive, and peptides move mainstream
